France Bed Holdings Co.,Ltd.

Informe acción TSE:7840

Capitalización de mercado: JP¥43.0b

France Bed HoldingsLtd Resultados de beneficios anteriores

Pasado controles de criterios 5/6

France Bed HoldingsLtd has been growing earnings at an average annual rate of 6.9%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 3.4% per year. France Bed HoldingsLtd's return on equity is 8.3%, and it has net margins of 5.3%.

Información clave

6.9%

Tasa de crecimiento de los beneficios

9.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare 7.9%
Tasa de crecimiento de los ingresos3.4%
Rentabilidad financiera8.3%
Margen neto5.3%
Próxima actualización de resultados08 Nov 2024

Actualizaciones de resultados anteriores recientes

Recent updates

France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

Mar 11
France Bed HoldingsLtd (TSE:7840) Will Pay A Larger Dividend Than Last Year At ¥21.00

France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Feb 26
France Bed HoldingsLtd (TSE:7840) Is Increasing Its Dividend To ¥21.00

Desglose de ingresos y gastos

Cómo gana y gasta dinero France Bed HoldingsLtd. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

TSE:7840 Ingresos, gastos y beneficios (JPY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Jun 2459,9973,17127,6140
31 Mar 2459,1513,13427,3020
31 Dec 2358,7052,63627,2880
30 Sep 2358,7002,71227,0930
30 Jun 2358,7822,77426,8610
31 Mar 2358,5782,70226,7130
31 Dec 2257,5542,54426,3930
30 Sep 2256,6642,49126,0210
30 Jun 2255,3922,34925,6450
31 Mar 2254,3982,55725,0810
31 Dec 2154,1132,62524,7630
30 Sep 2154,0102,74924,4990
30 Jun 2154,0512,77824,2900
31 Mar 2152,4302,29523,7920
31 Dec 2051,2051,95823,3020
30 Sep 2050,4991,70523,1180
30 Jun 2051,1941,54523,1180
31 Mar 2052,4301,52023,4250
31 Dec 1952,7552,91023,4930
30 Sep 1952,7972,57623,4130
30 Jun 1951,6462,42523,2640
31 Mar 1951,7642,59923,1280
31 Dec 1852,3331,57923,1330
30 Sep 1852,2071,74423,0280
30 Jun 1852,5291,90022,9220
31 Mar 1852,4101,80622,8280
31 Dec 1752,3062,20022,7900
30 Sep 1752,2412,09722,8590
30 Jun 1752,0511,88722,7980
31 Mar 1752,1261,93122,7560
31 Dec 1652,0081,20222,7030
30 Sep 1652,3771,33122,5640
30 Jun 1652,5491,38422,4400
31 Mar 1652,6441,40222,3100
31 Dec 1552,8601,36422,1950
30 Sep 1552,6091,18822,1920
30 Jun 1552,0771,03322,2410
31 Mar 1551,90790422,2910
31 Dec 1453,4221,00422,3960
30 Sep 1454,2031,14322,3040
30 Jun 1454,6081,31522,0730
31 Mar 1454,8911,39721,9390
31 Dec 1352,7281,28821,4790

Ingresos de calidad: 7840 has high quality earnings.

Margen de beneficios creciente: 7840's current net profit margins (5.3%) are higher than last year (4.7%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 7840's earnings have grown by 6.9% per year over the past 5 years.

Acelerando crecimiento: 7840's earnings growth over the past year (14.3%) exceeds its 5-year average (6.9% per year).

Beneficios vs. Industria: 7840 earnings growth over the past year (14.3%) exceeded the Healthcare industry 9.6%.

Rentabilidad financiera

Alta ROE: 7840's Return on Equity (8.3%) is considered low.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y